• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶CK2在乳腺肿瘤发生中的作用

Protein kinase CK2 in mammary gland tumorigenesis.

作者信息

Landesman-Bollag E, Romieu-Mourez R, Song D H, Sonenshein G E, Cardiff R D, Seldin D C

机构信息

Department of Medicine, Boston Medical Center, Boston, Massachusetts, MA 02118-2394, USA.

出版信息

Oncogene. 2001 May 31;20(25):3247-57. doi: 10.1038/sj.onc.1204411.

DOI:10.1038/sj.onc.1204411
PMID:11423974
Abstract

Protein kinase CK2 is a ubiquitous and evolutionarily conserved serine/threonine kinase that is upregulated in many human cancers and can serve as an oncogene in lymphocytes. Recently, we have demonstrated that CK2 potentiates Wnt/beta-catenin signaling in mammary epithelial cells. To determine whether CK2 overexpression contributes to mammary tumorigenesis, we have performed comparative studies of human and rat breast cancer specimens and we have engineered transgenic mice with dysregulated expression of CK2alpha in the mammary gland. We find that CK2 is highly expressed in human breast tumor specimens and in carcinogen-induced rat mammary tumors. Overexpression of CK2alpha in the mammary gland of transgenic mice, under control of the MMTV-LTR, causes hyperplasia and dysplasia of the female mammary gland. Thirty per cent of the female MMTV-CK2alpha transgenic mice develop mammary adenocarcinomas at a median of 23 months of age, often associated with Wnt pathway activation, as evidenced by upregulation of beta-catenin protein. NF-kappaB activation and upregulation of c-Myc also occur frequently. Thus, in mice, rats, and humans, dysregulated expression of CK2 is associated with and is capable of contributing to mammary tumorigenesis. Targeted inhibition of CK2 could be useful in the treatment of breast cancer.

摘要

蛋白激酶CK2是一种广泛存在且在进化上保守的丝氨酸/苏氨酸激酶,在许多人类癌症中上调,并且在淋巴细胞中可作为一种癌基因。最近,我们已经证明CK2在乳腺上皮细胞中增强Wnt/β-连环蛋白信号传导。为了确定CK2的过表达是否有助于乳腺肿瘤发生,我们对人类和大鼠乳腺癌标本进行了比较研究,并构建了乳腺中CK2α表达失调的转基因小鼠。我们发现CK2在人类乳腺肿瘤标本和致癌物诱导的大鼠乳腺肿瘤中高度表达。在MMTV-LTR的控制下,转基因小鼠乳腺中CK2α的过表达导致雌性乳腺增生和发育异常。30%的雌性MMTV-CK2α转基因小鼠在23个月龄的中位数时发生乳腺腺癌,通常与Wnt途径激活相关,β-连环蛋白蛋白上调证明了这一点。NF-κB激活和c-Myc上调也经常发生。因此,在小鼠、大鼠和人类中,CK2的表达失调与乳腺肿瘤发生相关并且能够促成乳腺肿瘤发生。对CK2的靶向抑制可能对乳腺癌治疗有用。

相似文献

1
Protein kinase CK2 in mammary gland tumorigenesis.蛋白激酶CK2在乳腺肿瘤发生中的作用
Oncogene. 2001 May 31;20(25):3247-57. doi: 10.1038/sj.onc.1204411.
2
Protein kinase CK2: signaling and tumorigenesis in the mammary gland.蛋白激酶CK2:乳腺中的信号传导与肿瘤发生
Mol Cell Biochem. 2001 Nov;227(1-2):153-65.
3
beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.β-连环蛋白是Wnt介导的乳腺肿瘤发生的下游效应分子。
Oncogene. 2001 Aug 23;20(37):5093-9. doi: 10.1038/sj.onc.1204586.
4
Endogenous protein kinase CK2 participates in Wnt signaling in mammary epithelial cells.内源性蛋白激酶CK2参与乳腺上皮细胞中的Wnt信号传导。
J Biol Chem. 2000 Aug 4;275(31):23790-7. doi: 10.1074/jbc.M909107199.
5
Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.Wnt 信号激活和 MMTV-LRP6 转基因小鼠的乳腺增生:对乳腺癌发生的影响。
Oncogene. 2010 Jan 28;29(4):539-49. doi: 10.1038/onc.2009.339. Epub 2009 Nov 2.
6
ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.表皮生长因子受体B(ErbB)-β-连环蛋白复合物与人类浸润性导管乳腺癌以及鼠乳腺肿瘤病毒(MMTV)-Wnt-1和MMTV-c-Neu转基因癌相关。
J Biol Chem. 2002 Jun 21;277(25):22692-8. doi: 10.1074/jbc.M201975200. Epub 2002 Apr 11.
7
Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.肿瘤抑制基因磷酸酶与张力蛋白同源物的过表达部分抑制Wnt-1诱导的乳腺肿瘤发生。
Cancer Res. 2005 Aug 1;65(15):6864-73. doi: 10.1158/0008-5472.CAN-05-0181.
8
CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling.β-连环蛋白犰狳重复区域的CK2磷酸化增强Wnt信号传导。
J Biol Chem. 2003 Jun 27;278(26):24018-25. doi: 10.1074/jbc.M212260200. Epub 2003 Apr 16.
9
Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.肢芽心(LBH)缺失可减弱 MMTV-Wnt1 转基因小鼠的乳腺增生和肿瘤发生。
Biochem Biophys Res Commun. 2019 Jan 8;508(2):536-542. doi: 10.1016/j.bbrc.2018.11.155. Epub 2018 Dec 1.
10
Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.蛋白激酶CK2促进核因子-κB的异常激活、转化表型及乳腺癌细胞的存活。
Cancer Res. 2002 Nov 15;62(22):6770-8.

引用本文的文献

1
Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α.化学生物组学揭示了外激酶 CK2α 的免疫原性和肿瘤相关细胞表面底物。
Cell Chem Biol. 2024 Sep 19;31(9):1729-1739.e9. doi: 10.1016/j.chembiol.2024.07.018. Epub 2024 Aug 22.
2
Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α.化学蛋白质组学揭示了胞外激酶CK2α的免疫原性和肿瘤相关细胞表面底物。
bioRxiv. 2024 Mar 20:2024.03.20.585970. doi: 10.1101/2024.03.20.585970.
3
Cell cycle-dependent gene networks for cell proliferation activated by nuclear CK2α complexes.
核 CK2α 复合物激活的细胞增殖的细胞周期依赖性基因网络。
Life Sci Alliance. 2023 Oct 31;7(1). doi: 10.26508/lsa.202302077. Print 2024 Jan.
4
High-throughput screening of the Saccharomyces cerevisiae genome for 2-amino-3-methylimidazo [4,5-f] quinoline resistance identifies colon cancer-associated genes.高通量筛选酿酒酵母基因组对 2-氨基-3-甲基咪唑[4,5-f]喹啉的抗性,鉴定出与结肠癌相关的基因。
G3 (Bethesda). 2023 Dec 6;13(12). doi: 10.1093/g3journal/jkad219.
5
Emodin attenuates high lipid-induced liver metastasis through the AKT and ERK pathways in breast cancer cells and in a mouse xenograft model.大黄素通过AKT和ERK信号通路抑制乳腺癌细胞及小鼠异种移植模型中高脂诱导的肝转移。
Heliyon. 2023 Jun 7;9(6):e17052. doi: 10.1016/j.heliyon.2023.e17052. eCollection 2023 Jun.
6
Antitumor activity of the protein kinase inhibitor 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines.蛋白激酶抑制剂 1-(β-D-2'-脱氧呋喃核糖基)-4,5,6,7-四溴-1H-苯并咪唑在乳腺癌细胞系中的抗肿瘤活性。
BMC Cancer. 2022 Oct 15;22(1):1069. doi: 10.1186/s12885-022-10156-8.
7
Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.蛋白激酶 CK2-在癌细胞生物学中的多种作用和治疗潜力。
Mol Cell Biochem. 2023 Apr;478(4):899-926. doi: 10.1007/s11010-022-04558-2. Epub 2022 Sep 17.
8
Targeting protein kinase CK2 in the treatment of cholangiocarcinoma.靶向蛋白激酶CK2治疗胆管癌。
Explor Target Antitumor Ther. 2021;2(5):434-447. doi: 10.37349/etat.2021.00055. Epub 2021 Oct 31.
9
CSNK2 in cancer: pathophysiology and translational applications.CSNK2 在癌症中的作用:病理生理学及转化应用
Br J Cancer. 2022 Apr;126(7):994-1003. doi: 10.1038/s41416-021-01616-2. Epub 2021 Nov 12.
10
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease.108600 同时抑制 CK2/TNIK/DYRK1,抑制三阴性乳腺癌干细胞和化疗耐药性疾病。
Nat Commun. 2021 Aug 3;12(1):4671. doi: 10.1038/s41467-021-24878-z.